Clinical Trial Update: Use of Continuous Wound Infusion of Bupivacaine for Analgesia Following Axillary Clearance Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating continuous wound infusion of bupivacaine for analgesia after axillary clearance surgery in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bupivacaine (Bupivacaine)

Snippet

Sponsor: Cork University Hospital | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN